We recently determined that a higher fraction of erythroid progenitors are contained within the CD34+ cell fraction in the marrow of SCD patients, suggesting improved collection and purification methods might be required for SCD gene therapy36. This evidence concerns the gene CD34 and Schnyder corneal dystrophy.